Top post @Ragnarolf !
Steini, what do you think happened with Hervaxx and what is the way forward? I think @Ragnarolf is right on the money (pardon the pun) with the interest from BP and the commercialisation aspects of it, which is all that matters, because it represents the value of the science / trials. Do you think IMU always had a plan to do more Ph2 combination trials? And why do you think the share price went up to 60c and has then declined? I think the speculation that Hervaxx would get licensed / sold off was the reason, not the potential of the other products.
Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA, page-97
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.003(5.00%) |
Mkt cap ! $415.2M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.5¢ | $763.7K | 13.34M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 700566 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 766939 | 21 |
View Market Depth
| Last trade - 11.13am 24/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |